Unfortunately in some ways it IS competition. THREAD (1/10) https://twitter.com/dr2nisreenalwan/status/1325515300595507201
The public has a limited attention span. Despite events like @unrestfilm and the National Academy of Med report, the public does not recognize #MECFS as a public health problem despite the fact that an estimated 1 million people have it. (2/10)
Obviously there is substantial competition for scientific resources. Last week NIH confirmed that their in-house study of #MECFS patients (which was already running behind schedule) has been paused since February. No re-start date set as far as I know. (4/10)
Competition for funding is a huge issue, of course. #MECFS causes an economic loss in the US of $30billion or more (incl lost productivity). The highest single year of NIH funding to extramural projects was in 2017: $13.3 Million http://occupyme.net/2017/10/03/bottom-of-the-ramp/ (5/10)
And NIH knows the urgency of the situation. I mentioned the 2015 NAM report, which NIH partially funded. In Oct 2015, Dr. Francis Collins said that NIH was going to reinvigorate and ramp up #MECFS funding. It was more like a bump up to 2017 and then flat. (7/10)
There is a reasonable desire among #LongCovid patients to avoid being lumped together with #MECFS patients, given the gaslighting, harmful practices claimed as “treatments,” and the lack of funding. And we don’t want to be left behind if the funding flows to #LongCovid (8/10)
Rather than admonishing #MECFS or other patients for speaking up about our experiences, it would be more productive to join and amplify our voices. We want what every sick person wants and deserves: compassionate and effective treatment. (10/10)
You can follow @jspotila.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: